Jiangsu, China

Jianwu Wang

This inventor holds 1 USPTO granted patent. Top assignees: Beijing Gefucure Biotechnology Limited Company, Wuxi Kingenew Biotechnology Limited Company. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianwu Wang. Retrieved from https://idiyas.com/inventor/jianwu-wang-9z5xtyre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jianwu Wang

Introduction

Jianwu Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on enhancing the efficacy of therapeutic drugs through innovative approaches.

Latest Patents

Wang holds a patent for an afucosylated monoclonal antibody. This invention provides a human IgG antibody with an afucosylated sugar chain structure at a heavy-chain sugar chain binding site. The monoclonal antibody has applications in the preparation of antineoplastic drugs. Compared to fucosylated monoclonal antibodies, Wang's afucosylated monoclonal antibody demonstrates higher biological activity both in vitro and in vivo. This advancement can lead to the development of more effective therapeutic monoclonal antibody drugs.

Career Highlights

Throughout his career, Jianwu Wang has worked with various biotechnology companies. Notably, he has been associated with Beijing Gefucure Biotechnology Limited Company and Wuxi Kingenew Biotechnology Limited Company. His experience in these organizations has contributed to his expertise in the field.

Collaborations

Wang has collaborated with several professionals in his field, including Bo Tang and Ran Zhang. These collaborations have likely enriched his research and development efforts.

Conclusion

Jianwu Wang's innovative work in the field of monoclonal antibodies showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact therapeutic drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…